Come up with a name for your new list and we'll add to it:
Okairos raised a round of funding on January 01, 2007. Investors include
Merck & Co..
Okairos is a clinical-stage biopharmaceutical company, developing genetic vaccines for major infectious diseases - including malaria, hepatitis C, HIV, respiratory syncytial virus and cancer - using a…